Total lymphoid irradiation in multiple sclerosis: blood lymphocytes and clinical course.
We have found a significant relationship between blood lymphocyte count and prognosis in 45 patients receiving either total lymphoid irradiation or sham irradiation for chronic progressive multiple sclerosis. Patients with sustained lymphocyte counts less than 900 mm-3 for prolonged periods after treatment showed less rapid progression over the ensuing 3 years than did patients with multiple sclerosis who had lymphocyte counts above this level (p less than 0.01). Our results suggest that a simple laboratory test, the absolute blood lymphocyte count, may serve as a valuable barometer for monitoring the amount of immunosuppressive therapy needed to prevent progression in patients with multiple sclerosis, and possibly other autoimmune diseases.
Neurology Service, Veterans Administration Medical Center, East Orange, NJ 07019.
S D
SD
Cook
C
C
Devereux
R
R
Troiano
G
G
Zito
M
M
Hafstein
M
M
Lavenhar
E
E
Hernandez
P C
PC
Dowling
D000328:Adult; D002452:Cell Count; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism / Q000528:radiation effects*; D008221:Lymphoid Tissue / Q000503:physiopathology / Q000528:radiation effects*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000503:physiopathology / Q000532:radiotherapy*; D011379:Prognosis; D013997:Time Factors